Ramón Lecumberri
University of Navarra
140 Papers
842 Citations
Ramón Lecumberri is an academic researcher from University of Navarra. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 27, co-authored 118 publications. Previous affiliations of Ramón Lecumberri include Carlos III Health Institute.
Chat about Author
Papers
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge,Philippe Debourdeau,M Beckers,C. Baglin,Rupert Bauersachs,Barry M. Brenner,Dialina Brilhante,Anna Falanga,G T Gerotzafias,Nissim Haim,Ajay K. Kakkar,Alok A. Khorana,Ramón Lecumberri,Mario Mandalà,Michel Marty,Manuel Monreal,Shaker A. Mousa,Simon Noble,Ingrid Pabinger,Paolo Prandoni,Martin H. Prins,Mohammed H. Qari,Michael B. Streiff,Konstantinos N. Syrigos,Henri Bounameaux,H. R. Büller +25 more
TL;DR: The use of LMWH for VTE prevention in cancer patients undergoing laparoscopic surgery may be recommended as for laparotomy and mechanical methods are not recommended as monotherapy except when pharmacological methods are contraindicated.
668
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Dominique Farge,Dominique Farge,Corinne Frere,Jean M. Connors,Cihan Ay,Alok A. Khorana,Andrés Muñoz,Benjamin Brenner,Ajay K. Kakkar,Hanadi Rafii,Susan Solymoss,Dialina Brilhante,Manuel Monreal,Henri Bounameaux,Ingrid Pabinger,James D. Douketis,Walter Ageno,Fernando Ajauro,Kamal R. Al-Aboudi,Thierry Alcindor,Thierry André,Pantep Angchaisuksiri,Darko Antic,Juan I. Arcelus,Eric Assenat,Kenneth A. Bauer,Ali Bazarbachii,I. Benzidia,Jan Beyer-Westendorf,Viktoria Bitsadze,Dorit Blickstein,Mark Blostein,Isabel Bogalho,Barbara Bournet,Patricia Casais,Antoine F. Carpentier,Gabriela Cesarman-Maus,Joydeep Chakbrabartty,Hugo A. Clemente,Jérôme Connault,Ludovic Doucet,Cécile Durant,Joseph Emmerich,Anna Falanga,Clemens Feistritzer,Carme Font,Charles W. Francis,Enrique Gallardo,Thomas Gary,Jean-Christophe Gris,Cecilia Guillermo,A. Hij,Russel D. Hull,Takayuki Ikezoe,Luis Jara-Palomares,Nigel S. Key,Jamilya Khrizroeva,Maral Koolian,Florian Langer,Ramón Lecumberri,Lai Heng Lee,Howard A. Liebman,Luisa Lopes Dos Santos,Duarte Henrique Machado,Isabelle Madelaine,Alexander Makatsariya,Mario Mandalà,Anthony Marayevas,Zora Marjanovic,Christine Marosi,Ellis Martin,Luis Meillon,Emmanuel Messas,Antonio Moreira,Ahmet M. Demir,Arlette Ndour,Michel Nguessan,Remedios Otero-Candelera,Vanessa Pachon Olmos,Ana Pais,Florian Posch,Matthias Preusser,Hanno Riess,Marc Philip Righini,Cynthia Rothschild,Andre Roussin,José Antonio Rueda-Camino,Pedro Ruiz-Artacho,Sanjith Saseedharan,Ali Shamseddine,Gerald A. Soff,Hans Stricker,Vicky Tagalakis,Ali T. Taher,Toutou Toussaint,Javier Trujillo-Santos,Stéphane Villiers,Raymond S.M. Wong,Norizaku Yamada +98 more
TL;DR: The 2019 International Initiative on Thrombosis and Cancer clinical practice guidelines, which are based on a systematic review of the literature published up to December, 2018, are presented along with a Grading of Recommendations Assessment Development and Evaluation scale methods.
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.
Philippe Debourdeau,Dominique Farge,M Beckers,C. Baglin,Rupert Bauersachs,Barry M. Brenner,Dialina Brilhante,Anna Falanga,G T Gerotzafias,Nissim Haim,Ajay K. Kakkar,Alok A. Khorana,Ramón Lecumberri,Mario Mandalà,Michel Marty,Manuel Monreal,Shaker A. Mousa,Simon Noble,Ingrid Pabinger,Paolo Prandoni,Martin H. Prins,Mohammed H. Qari,Michael B. Streiff,Konstantinos N. Syrigos,H. R. Büller,Henri Bounameaux +25 more
TL;DR: This work found no prospective randomized studies, two non‐randomized prospective studies and one retrospective study examining the efficacy and safety of low‐molecular‐weight heparin plus vitamin K antagonists (VKAs) examining the management of CRT in cancer patients, and no standard approach in terms of AC duration has been established.
293
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline†.
A. Falanga,Cihan Ay,Marcello Di Nisio,Grigorios T. Gerotziafas,Florian Langer,Ramón Lecumberri,Mario Mandalà,A. Maraveyas,Ingrid Pabinger,Luis Jara-Palomares,Marianne Sinn,K. N. Syrigos,A. Young,Kevin Jordan +13 more
TL;DR: Horváth-Puhó et al. as discussed by the authors found that the risk of venous thromboembolism in cancer patients is higher than in those without cancer across all age categories.
171
Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
Antonio Gómez-Outes,Ana Isabel Terleira-Fernández,Ana Isabel Terleira-Fernández,Ramón Lecumberri,M. Luisa Suárez-Gea,Emilio Vargas-Castrillón,Emilio Vargas-Castrillón +6 more
TL;DR: The DOAC seem as effective as, and probably safer than standard treatment of acute VTE, and the relative efficacy and safety of the DOAC was consistent across a wide range of patients.
125